Speranza Donatella Rubattu

researcher

Speranza Donatella Rubattu is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-5921-7368
0000-0002-9808-7970
P1153Scopus author ID7005952042

P69educated atUniversity of SassariQ532822
P108employerSapienza University of RomeQ209344
Faculty of Medicine and Psychology, Sapienza University of RomeQ45135477
P735given nameSperanzaQ3966508
SperanzaQ3966508
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q38656292A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat.
Q37209940A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.
Q61783469A Survey on Blood Pressure Levels and Hypertension Control in a Sample of the Italian General Population
Q46385948A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines
Q59622852A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians
Q59622860A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study
Q70489199Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure
Q48402388Altered regulation of endothelin A receptor subtype in the cerebral arterioles in response to a Japanese-style diet, in stroke-prone hypertensive rats
Q73175866Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat
Q59380044Aminoterminal natriuretic peptide as a determinant of PAI-1 levels in a sample of the adult male Italian population
Q51050321An easy and reproducible parameter for the assessment of the pressure gradient in patients with aortic stenosis disease: A magnetic resonance study.
Q38534772Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy.
Q70526618Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts
Q67593276Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure
Q37357298Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats.
Q48369215Association of a single nucleotide polymorphism of the NPR3 gene promoter with early onset ischemic stroke in an Italian cohort
Q48459991Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
Q37195866Atrial natriuretic Peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation
Q59622853Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans
Q38092606Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies
Q28250065Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans
Q61783490Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles
Q33812913C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.
Q38316737C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.
Q43076955C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro
Q91317685Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: A State of the Art
Q37901662Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.
Q46332264Common genetic variants in selected Ca²⁺ signaling genes and the risk of appropriate ICD interventions in patients with heart failure.
Q53923149Contribution of genetic factors to renal lesions in the stroke-prone spontaneously hypertensive rat.
Q61783487Correspondence
Q61783484Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat
Q43068711Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
Q42316713Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway
Q45971592Differential modulation of uncoupling protein 2 in kidneys of stroke-prone spontaneously hypertensive rats under high-salt/low-potassium diet.
Q50112681Early-onset ischaemic stroke: analysis of 58 polymorphisms in 17 genes involved in methionine metabolism
Q42165161Effect of a regulatory mutation on the rat atrial natriuretic peptide gene transcription.
Q54188881Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients
Q96580482Epigenetic control of natriuretic peptides: implications for health and disease
Q72050842Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy
Q34065857Etiology and pathophysiology of stroke as a complex trait
Q61783471Evaluation of Systolic Properties in Hypertensive Patients With Different Degrees of Diastolic Dysfunction and Normal Ejection Fraction
Q58464204Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy
Q34207430Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure
Q40742874Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts.
Q59622864Gene polymorphisms of the renin???angiotensin???aldosterone system and the risk of ischemic stroke
Q48502714High natriuretic peptide levels and low DBP: companion markers of cardiovascular risk?
Q68034026Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy
Q48730177Human coronary atherosclerosis modulates cardiac natriuretic peptide release.
Q36035785Hypertension and heart failure: role of neurohormonal mechanisms
Q38117232Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage
Q49141329Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol
Q48492870Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats
Q35642921In the search for stroke genes: a long and winding road
Q70492690Influence of hypercholesterolemia on adrenal steroid metabolism and electrolyte balance in spontaneously hypertensive rats
Q73595845Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition
Q61783475Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome
Q28077854Mitochondrial Dysfunction Contributes to Hypertensive Target Organ Damage: Lessons from an Animal Model of Human Disease
Q67898757Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits
Q42666163Molecular cloning and expression of rat kallistatin gene
Q37914058Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.
Q37766468NPR-C: a component of the natriuretic peptide family with implications in human diseases.
Q40847969NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation
Q55055397NT-proANP circulating level is a prognostic marker in stable ischemic heart disease.
Q59624975NT-proANP/ANP is a Determinant of Vascular Damage in Humans
Q44214089NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis.
Q37626852Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications
Q31126960Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
Q38162429Natriuretic peptides in cardiovascular diseases: current use and perspectives
Q37157505Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
Q28578344Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human Disease
Q26865574New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart
Q57549294No association between chromosome 12p13 single nucleotide polymorphisms and early-onset ischemic stroke
Q38165049Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?
Q27015633Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress
Q24600189Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians
Q26778562Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art
Q59622861Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population
Q38184967Polypharmacy in heart failure patients.
Q42799896Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up study
Q54282390Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPARα/UCP2 axis
Q61783467Pulmonary embolism in pregnancy
Q43287306Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro.
Q48474397Reciprocal congenic lines for a major stroke QTL on rat chromosome 1.
Q41084345Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.
Q61783477Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass
Q72331322Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT1 receptors in renin transgenic rats
Q44052509Relation between urinary kallikrein excretion and blood pressure response to a single oral dose of captopril
Q37991856Renin as a biomarker of cardiovascular disease in clinical practice.
Q38854043Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HF
Q100388307Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease
Q60647401Role of NOX2 in mediating doxorubicin-induced senescence in human endothelial progenitor cells
Q61783486Role of angiotensin II AT 1 and AT 2 subtype receptors in the regulation of atrial natriuretic peptide expression in salt-restricted rats
Q35918412Role of genetic factors in the etiopathogenesis of cerebrovascular accidents: from an animal model to the human disease.
Q37387706Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
Q73833066Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats
Q53291322RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure
Q44077525Short-term efficacy of nifedipine in essential and renovascular hypertension.
Q41727852T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients.
Q50055077T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients.
Q35425744The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells
Q48284904The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients.
Q56985191The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes
Q73092438The gene encoding atrial natriuretic peptide and the risk of human stroke
Q91941818The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome
Q68252366Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid
Q44903311Trypsin activation of human and cat prorenin: a comparative study.
Q59622854β2-Adrenergic Receptor Gene Polymorphisms and Risk of Ischemic Stroke

Search more.